The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX)

General Pharmacology

Volumn 33, Issue 4, 1999, Pages 341-346

  Giverhaug, Trude ^a   Loennechen, Thrina ^a   Aarbakke, Jarle ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

6 Mercaptopurine; Interaction; Methotrexate

Indexed keywords

MERCAPTOPURINE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG METABOLISM; NONHUMAN; PRIORITY JOURNAL;

6-MERCAPTOPURINE; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; DRUG INTERACTIONS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; METHOTREXATE;

EID: 0032856425     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(99)00022-1     Document Type: Article

References (22)

1. Aarbakke J., Janka-Schaub G., Elion G.B. Thiopurine biology and pharmacology. TiPS. 18:1997;3-7.
2. Alaoui S.E., Lawry J., Griffin M. The cell cycle and induction of apoptosis in a hamster fibrosarcoma cell line treated with anti-cancer drugs. its importance to solid tumour chemotherapy J Neuro-Oncol. 31:1997;195-207.
3. Balis F.M., Holcenberg J.S., Zimm S., Tubergen D., Collins J.M., Murphy R.F., Gilchrist G.S., Hammond D., Poplack D.G. The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clin Pharmacol Ther. 41:1987;384-387.
4. Burchenal J.H., Murphy M.L., Ellison R.R., Sykes M.P., Tan T.-C., Leone L.A., Karnovsky D.A., Craver L.F., Dargeon H.W., Rhoads C.P. Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases. Blood. 8:1953;965-999.
5. Bökkerink J.P.M., Bakker M.A.H., Hulscher T.W., De Abreu R.R.A., Schretlen E.D.A.M., van Laarhoven J.P.R.M., De Bruyn C.H.M.M. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts. Biochem Pharmacol. 35:1986;3549-3555.
6. Bökkerink J.P.M., Damen F.J.M., Hulscher M.W., Bakker M.A.H., De Abreu R.A. Biochemical evidence for synergistic combination treatment with methotrexate and 6-mercaptopurine in acute lymphoblastic leukemia. Hematol Blood Transf. 33:1990;110-117.
7. Da Silva C.P., De Oliveira C.R., De Lima M.C.P. Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes. Biochem Pharmacol. 51:1996;1331-1340.
8. Farber S., Diamond L.K., Mercer R.D., Sylvester R.F., Wolff Ja. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med. 238:1948;787-793.
9. Fiskarstrand T., Ueland P.M., Refsum H. Folate depletion induced by methotrexate affects methionine synthase activity and its susceptibility to inactivation by nitrous oxide. J Pharmacol Exp Ther. 282:1997;1305-1311.
10. Giverhaug T., Fuskevaag O.-M., Aarbakke J. Methotrexate increases red blood cell concentrations of 6-methylmercaptopurine ribonucleotide in rats in vivo. Cancer Chemother Pharmacol. 40:1997;367-370.
11. Giverhaug T., Loennechen T., Aarbakke J. Increased concentrations of methylated 6-mercaptopurine metabolites and 6-thioguanine nucleotides in human leukemic cells in vitro by methotrexate. Biochem Pharmacol. 55:1998;1641-1646.
12. Hortelano S., Bosca L. 6-Mercaptopurine decreases the Bcl-2/Bax ratio and induces apoptosis in activated splenic B-lymphocytes. Mol Pharmacol. 51:1997;414-421.
13. Innocenti F., Danesi R., Di Paolo A., Loru B., Favre C., Nardi M., Bocci G., Nardini D., Macchia P., Del Tacca M. Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate. Cancer Chemother Pharmacol. 37:1996;409-414.
14. Lamboov L.H.J., Leegwater P.A.J., Van den Heuvel L.P., Bokkerink J.P., De Abreu R.A. Inhibition of DNA methylation in malignant MOLT F4 lymphoblasts by 6-mercaptopurine. Clin Chem. 44:1998;556-559.
15. Lehninger A.L., Nelson D.L., Cox M.M. Principles of biochemistry. 2nd ed:1993;Worth Publishers, New York.
16. Lennard L., Lilleyman J.S., Maddocks J.L. The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia. Br J Cancer. 53:1986;115-119.
17. Lennard L., Van Loon J., Lilleyman J.S., Weinshilboum R.M. Thiopurine pharmacogenetics in leukemia. correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations Clin Pharmacol Ther. 41:1987;18-25.
18. Nord L.D., Stolfi R.L., Alfieri A.A., Netto G., Reuter V., Sternberg S.S., Colofiore J.R., Koutcher J.A., Martin D.S. Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion. Cancer Chemother Pharmacol. 40:1997;376-384.
19. Poplack D.G., Kun L.E., Magrath I.T., Pizzo P.A. Leukemias and lymphomas of childhood. DeVita V.T., Hellman S., Rosenberg S.A. Caner. Prinicples and practice of oncology 4th ed:1993;1792-1818 JB Lippincott Co, Philadelphia.
20. Stet E.H., De Abreu R.A., Bökkerink J.P.M., Blom H.J., Lamboy L.H.J., Vogels-Mentink T.M., De Graaf-Hess A.C., Van Raay Selten B., Trijbels F.J.M. Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts. Biochem J. 304:1994;163-168.
21. Thomas, C.L. (Ed.), 1981. Taber's cyclopedic medical dictionary, 14th ed. F.A. Davis, Philadelphia.
22. Van Ede A.E., Laan R.F.J.M., Blom H.J. Methotrexate in rheumatiod arthritis. an update with focus on mechanisms involved in toxicity Semin Arthritis Rheum. 27:1998;277-292.